104 related articles for article (PubMed ID: 8414499)
1. MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression.
Cromme FV; Snijders PJ; van den Brule AJ; Kenemans P; Meijer CJ; Walboomers JM
Oncogene; 1993 Nov; 8(11):2969-75. PubMed ID: 8414499
[TBL] [Abstract][Full Text] [Related]
2. [The possibility of viral etiology in cervical carcinogenesis].
Iwasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):802-11. PubMed ID: 2172417
[TBL] [Abstract][Full Text] [Related]
3. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
4. Nonradioactive RNA in situ hybridization detection of human papillomavirus 16-E7 transcripts in squamous cell carcinomas of the uterine cervix using confocal laser scan microscopy.
van den Brule AJ; Cromme FV; Snijders PJ; Smit L; Oudejans CB; Baak JP; Meijer CJ; Walboomers JM
Am J Pathol; 1991 Nov; 139(5):1037-45. PubMed ID: 1719818
[TBL] [Abstract][Full Text] [Related]
5. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
6. Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
Cromme FV; Meijer CJ; Snijders PJ; Uyterlinde A; Kenemans P; Helmerhorst T; Stern PL; van den Brule AJ; Walboomers JM
Br J Cancer; 1993 Jun; 67(6):1372-80. PubMed ID: 8390286
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
8. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes.
Tate JE; Mutter GL; Prasad CJ; Berkowitz R; Goodman H; Crum CP
Gynecol Oncol; 1994 Apr; 53(1):78-83. PubMed ID: 8175026
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus, human cytomegalovirus and oncogene C-myc in cervical carcinoma and cervicitis.
Huang SL; Liu ZQ; Zhang XN; Li MJ
Chin Med J (Engl); 1993 Mar; 106(3):208-10. PubMed ID: 8391967
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.
Schlott T; Eiffert H; Bohne W; Landgrebe J; Brunner E; Spielbauer B; Knight B
Gynecol Oncol; 2005 Sep; 98(3):409-19. PubMed ID: 16005053
[TBL] [Abstract][Full Text] [Related]
12. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of human papillomavirus type 16 DNA sequences and c-myc oncogene alterations in uterine-cervix carcinoma.
Ocádiz R; Sauceda R; Salcedo M; Ortega V; Rodríguez H; Gordillo C; Chávez P; Gariglio P
Arch Invest Med (Mex); 1989; 20(4):355-62. PubMed ID: 2562235
[TBL] [Abstract][Full Text] [Related]
14. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
15. HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter.
Li H; Ou X; Xiong J; Wang T
Biochem Biophys Res Commun; 2006 Nov; 349(4):1315-21. PubMed ID: 16979588
[TBL] [Abstract][Full Text] [Related]
16. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva MR; Garrido F
Cancer Res; 1991 May; 51(9):2463-8. PubMed ID: 1849792
[TBL] [Abstract][Full Text] [Related]
17. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
18. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.
Bottley G; Watherston OG; Hiew YL; Norrild B; Cook GP; Blair GE
Oncogene; 2008 Mar; 27(12):1794-9. PubMed ID: 17828295
[TBL] [Abstract][Full Text] [Related]
19. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors.
Peter M; Rosty C; Couturier J; Radvanyi F; Teshima H; Sastre-Garau X
Oncogene; 2006 Sep; 25(44):5985-93. PubMed ID: 16682952
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the expression of major histocompatibility complex class I genes in human colorectal cancer.
Soong TW; Hui KM
Cancer Detect Prev; 1991; 15(3):231-9. PubMed ID: 1905582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]